BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1008988)

  • 21. Reactivity in the MEM-test of cancer patients' lymphocytes incubated with brain-derived preparations and extracts from malignant teratomas.
    Müller M; Irmscher J; Grossmann H; Kotzsch M; Wagner H; Kemmer C
    Arch Geschwulstforsch; 1981; 51(4):354-63. PubMed ID: 6172087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on lymphocyte sensitization to encephalitogenic protein in tumor patients.
    Cerni CH; Micksche M
    Acta Neuropathol Suppl; 1975; Suppl 6():65-8. PubMed ID: 50710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The macrophage electrophoretic mobility (MEM) test for the diagnosis of hydatidiform mole and choriocarcinoma. Preliminary report.
    Klausch B; Straube W; Hofmann R; Büttner HH; Jenssen HL; Köhler H; Günther J
    Ann Chir Gynaecol; 1977; 66(4):209-13. PubMed ID: 71873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The macrophage electrophoretic migration test in cancer.
    Goldstone AH; Kerr L; Irvine WJ
    Clin Exp Immunol; 1973 Jul; 14(3):469-72. PubMed ID: 4125154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The macrophage electrophoretic mobility test for malignancy.
    Lubran MM
    Ann Clin Lab Sci; 1974; 4(2):121-4. PubMed ID: 4132114
    [No Abstract]   [Full Text] [Related]  

  • 26. [Macrophage electrophoretic mobility inhibition test (MET) in immunological diagnosis of malignant lymphomas in Papio baboons].
    Indzhiia LV; Iakovleva LA; Lapin BA; Tsaturian TN; Malkovskiĭ M
    Vopr Onkol; 1980; 26(11):66-71. PubMed ID: 7456428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response of lymphocytes from cancer patients to human chorionic gonadotrophin.
    Wass M; Rawlins GA; Pentycross CR; Bagshawe KD
    Lancet; 1977 Jan; 1(8004):171-2. PubMed ID: 64701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The macrophage electrophoretic migration (MEM) test for lymphocyte sensitization. A study of the kinetics.
    Carnegie PR; Caspary EA; Dickinson JP; Field EJ
    Clin Exp Immunol; 1973 May; 14(1):37-45. PubMed ID: 4716103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophage electrophoretic mobility (MEM) test in malignant gynaecological diseases.
    Jenssen HL; Köhler H; Günther J; Klausch B; Straube W; Hofmann R; Büttner HH
    Arch Gynakol; 1976 Mar; 220(3):191-8. PubMed ID: 773334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the kinetics of the macrophage electrophoretic mobility (MEM) and the tanned sheep erythrocyte electrophoretic mobility (TEEM) tests.
    Shenton BK; Jenssen HL; Werner H; Field EJ
    J Immunol Methods; 1977; 14(2):123-39. PubMed ID: 138709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bovine myelin basic protein: immunochemical specificity examined by the macrophage migration inhibition test.
    Bergstrand H
    Acta Pathol Microbiol Scand C; 1977 Aug; 85C(4):225-32. PubMed ID: 899797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Reaction of inhibition of macrophage electrophoretic mobility in differential diagnosis of carcinomas].
    Miuller M; Irmsher Iu; Fisher R; Grosmann G
    Vopr Onkol; 1976; 22(12):43-50. PubMed ID: 1020256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The macrophage electrophoretic mobility test: Results on carcinoma of the colon and rectum.
    Glaves D; Harlos JP; Weiss L
    Int J Cancer; 1977 Apr; 19(4):474-81. PubMed ID: 66210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Responses of cancer patients in the MEM test: not just a function of charge on basic proteins.
    Shaw A; Ettin G; McPherson TA
    Br J Cancer; 1976 Jul; 34(1):7-13. PubMed ID: 60119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunodiagnostics of malignant disease. VI. Electrophoretic mobility test (EMT) in malignant melanoma.
    Douwes FR; Spellmann HJ; Mross K; Wolfrum DI
    Oncology; 1978; 35(4):163-7. PubMed ID: 81476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophage electrophoretic migration (MEM) test for lymphocyte sensitization: some practical experiences in macrophage selection.
    Shenton BK; Hughes D; Field EJ
    Br J Cancer Suppl; 1973 Aug; 1():215-8. PubMed ID: 4804280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical assessment of the MOD-MEM cancer test in controls with non-malignant diseases.
    Pritchard JA; Moore JL; Sutherland WH; Joslin CA
    Br J Cancer; 1976 Jul; 34(1):1-6. PubMed ID: 60118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunodiagnostics of malignant diseases. II. The electrophoretic mobility test in the diagnosis of gynecological malignancies.
    Douwes FR; Hoffmann W; Mross K
    Oncology; 1977; 34(2):80-3. PubMed ID: 70771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophage-electrophoretic-mobility (M.E.M.) test for malignant disease. An independent confirmation.
    Pritchard JA; Moore JL; Sutherland WH; Joslin CA
    Lancet; 1972 Sep; 2(7778):627-9. PubMed ID: 4116778
    [No Abstract]   [Full Text] [Related]  

  • 40. The diagnostic problem in multiple sclerosis (M.S.): two specific laboratory tests.
    Field EJ
    Boll Ist Sieroter Milan; 1978 Jan; 56(6):552-6. PubMed ID: 75734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.